Latest filing published 08 Apr 2021 for Processa Pharmaceuticals, Inc., €292k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +61.9%Entry US$2,375.00 · Close at T+365 US$3,845.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James E. Besser: trading record in brief
This profile gathers the share dealings of James E. Besser across 2 companies, led by Processa Pharmaceuticals, Inc. and Medifirst Solutions, Inc. Between 1 May 2019 and 8 April 2021, the trades on record add up to 14 filings.
In open-market terms, that means 2 purchases worth €109k on one side and 12 sales worth €8.6M on the other. The net balance comes to €8.5M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2021 alone, the filings show no purchases and 12 sales.
Most recently, on 5 May 2021, the filings show an open-market sale worth €28k in Processa Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,217 days ago, on 13 October 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 8 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James E. Besser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,771 shares@ US$10.916.6% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-002824:0
- 16,000 shares@ US$10.673.2% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-002824:1
- 400,000 shares@ US$10.7681.6% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-002824:2
- 5,000 shares@ US$11.351.1% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-001888:0
- 3,000 shares@ US$11.200.6% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-001888:1
- 20,929 shares@ US$11.564.5% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-001888:2
- 30,000 shares@ US$4.0423.3% of flowCommon SharesSEC:0000919574-20-006339:0Canonical exit: 31 Dec 2020 (T+90)
- 96,612 shares@ US$0.07100.0% of flowCommon StockSEC:0000919574-19-003109:0Canonical exit: 30 Jul 2019 (T+90)
8 of 8 declarations
